A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
TC El‐Galaly, AE Bilgrau… - British Journal of …, 2015 - Wiley Online Library
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single‐agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single‐agent rituximab is an alternative for these patients. In this …
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
TC El-Galaly, AE Bilgrau… - British Journal of …, 2015 - portal.findresearcher.sdu.dk
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
TC El-Galaly, AE Bilgrau, P de Nully Brown… - British Journal of …, 2015 - vbn.aau.dk
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
TC El-Galaly, AE Bilgrau… - British Journal of …, 2015 - research.regionh.dk
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
A population‐based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
TC El‐Galaly, AE Bilgrau, PN Brown, KJ Mylam… - British Journal of …, 2015 - infona.pl
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single‐agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single‐agent rituximab is an alternative for these patients. In this …
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
TC El-Galaly, AE Bilgrau, P de Nully Brown… - British Journal of …, 2015 - europepmc.org
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
TC El‐Galaly, AE Bilgrau… - British Journal of …, 2015 - search.ebscohost.com
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait
TC El-Galaly, AE Bilgrau… - British journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …
lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this …